✦ LIBER ✦

Active, specific immunotherapy of murine leukemia. II. Adjuvant effect of Corynebacterium parvum

✍ Scribed by Gerald L. Bartlett; John W. Kreider

Publisher: John Wiley and Sons
Year: 1979
Tongue: French
Weight: 796 KB
Volume: 24
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910240518

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We have previously shown that irradiated LSTRA cells (LX) were immunogenic and could prolong survival of mice bearing LSTRA tumors. This study demonstrated that addition of Corynebacterium parvum to the LX dramatically improved the strength of tumor immunity. In pretreatment‐challenge experiments, C. parvum augmented the immunogenicity of 10^6^ LX given intradermally, with an optimum dose of 0.14–1.4 μg C. parvum per mouse. In therapy experiments (intraperitoneal vaccine treatment after tumor cell challenge), the therapeutic effect of 10^7^ LX was improved by admixture of C. parvum, leading to a larger number of cured mice, permitting treatment of a larger challenge inoculum, and allowing later initiation of treatment than was possible with LX alone. Optimal dose of C. parvum for therapy was 1,400 μg per mouse. Presensitization to C. parvum or use of repeated vaccine injections did not further improve the therapeutic effect. Cure of tumor‐bearing mice by the mixed vaccine was tumor‐specific. These results suggest that C. parvum is a potent adjuvant for use in active, tumor‐specific immunotherapy.

📜 SIMILAR VOLUMES

Active, specific immunotherapy of murine

Active, specific immunotherapy of murine leukemia. I. Irradiated tumor cell vaccine

✍ Gerald L. Bartlett; John W. Kreider; Dallas M. Purnell 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 French ⚖ 674 KB

## Abstract This report describes a new animal model for active, specific, systemic immunotherapy of leukemia. Mice were challenged (day 0) with 10^3^ viable LSTRA cells and treated later with a vaccine containing 10^7^ irradiated LSTRA cells. Four intraperitoneal or intravenous vaccine injections,

Mechanism of Corynebacterium parvum anti

Mechanism of Corynebacterium parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice

✍ Cypka Mazurek; Huguette Chalvet; Claude Stiffel; Guido Biozzi 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 French ⚖ 282 KB 👁 1 views

## Abstract The natural resistance to syngeneic mammary carcinoma was reduced by thymectomy alone in adult C~3~H mice or in mice thymectomized, lethally irradiated and restored with bone‐marrow cells (Tx RB). The protective effect of __C. parvum__ was not modified by adult thymectomy but it was red

Induction of graft versus leukemia effec

Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia

✍ Lola Weiss; Samir Nusair; Shoshana Reich; Haim Sidi; S. Slavin 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 165 KB

Allogeneic CD3/CD28 cross-linked Th1 mem

Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma

✍ M. Har-Noy; M. Zeira; L. Weiss; E. Fingerut; R. Or; S. Slavin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 846 KB

The breaking of peripheral T-cell tolerance toward self-antigens expressed by tumor cells and the subsequent establishment of an effective tumor protective immune response remains a major challenge for cancer immunotherapy. We report that both protective and therapeutic anti-tumor immune responses c